William F. Doyle
2019
In 2019, William F. Doyle earned a total compensation of $8.3M as Executive Chairman at NovoCure, a 82% increase compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $891,000 |
---|---|
Option Awards | $4,972,114 |
Salary | $750,000 |
Stock Awards | $1,654,987 |
Other | $18,000 |
Total | $8,286,101 |
Doyle received $5M in option awards, accounting for 60% of the total pay in 2019.
Doyle also received $891K in non-equity incentive plan, $750K in salary, $1.7M in stock awards and $18K in other compensation.
Rankings
In 2019, William F. Doyle's compensation ranked 1,037th out of 13,971 executives tracked by ExecPay. In other words, Doyle earned more than 92.6% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 1,037 out of 13,971 | 93rd |
Division Manufacturing | 354 out of 5,701 | 94th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 43 out of 832 | 95th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 24 out of 535 | 96th |
Industry Surgical and Medical Instruments and Apparatus | 12 out of 350 | 97th |
Source: SEC filing on April 27, 2020.
Doyle's colleagues
We found four more compensation records of executives who worked with William F. Doyle at NovoCure in 2019.